Ana Checa-Ros

412 total citations
24 papers, 255 citations indexed

About

Ana Checa-Ros is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Ana Checa-Ros has authored 24 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Surgery. Recurrent topics in Ana Checa-Ros's work include Attention Deficit Hyperactivity Disorder (7 papers), Sleep and related disorders (3 papers) and Circadian rhythm and melatonin (3 papers). Ana Checa-Ros is often cited by papers focused on Attention Deficit Hyperactivity Disorder (7 papers), Sleep and related disorders (3 papers) and Circadian rhythm and melatonin (3 papers). Ana Checa-Ros collaborates with scholars based in Spain, United Kingdom and Colombia. Ana Checa-Ros's co-authors include Antonio Muñoz‐Hoyos, Antonio Molina‐Carballo, Antonio Jeréz-Calero, Cristina Campoy, Luis D’Marco, J. Uberos, Valmore Bermúdez, Antonio Muñoz, Dorothée Kasteleijn‐Nolst Trenité and Stefano Seri and has published in prestigious journals such as International Journal of Molecular Sciences, Nutrients and Psychiatry Research.

In The Last Decade

Ana Checa-Ros

23 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Checa-Ros Spain 9 82 66 52 50 39 24 255
Fude Yang China 12 149 1.8× 57 0.9× 96 1.8× 17 0.3× 39 1.0× 28 391
Sjors M. M. Lange Netherlands 4 154 1.9× 50 0.8× 103 2.0× 17 0.3× 105 2.7× 5 389
Victoria Sanborn United States 10 44 0.5× 89 1.3× 27 0.5× 14 0.3× 89 2.3× 25 282
Katherine Semenkovich United States 8 38 0.5× 36 0.5× 47 0.9× 26 0.5× 73 1.9× 16 501
Hohui E. Wang Taiwan 6 45 0.5× 85 1.3× 51 1.0× 11 0.2× 65 1.7× 7 342
Dariusz Juchnowicz Poland 12 66 0.8× 109 1.7× 100 1.9× 9 0.2× 60 1.5× 42 360
Erhan Kurt Türkiye 10 198 2.4× 33 0.5× 24 0.5× 14 0.3× 44 1.1× 27 382
Maria Chiara Santovito Italy 8 60 0.7× 43 0.7× 43 0.8× 11 0.2× 28 0.7× 10 247
Elżbieta Trafalska Poland 14 61 0.7× 62 0.9× 89 1.7× 51 1.0× 150 3.8× 28 480
Christine Girard France 8 49 0.6× 50 0.8× 23 0.4× 22 0.4× 51 1.3× 14 310

Countries citing papers authored by Ana Checa-Ros

Since Specialization
Citations

This map shows the geographic impact of Ana Checa-Ros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Checa-Ros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Checa-Ros more than expected).

Fields of papers citing papers by Ana Checa-Ros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Checa-Ros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Checa-Ros. The network helps show where Ana Checa-Ros may publish in the future.

Co-authorship network of co-authors of Ana Checa-Ros

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Checa-Ros. A scholar is included among the top collaborators of Ana Checa-Ros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Checa-Ros. Ana Checa-Ros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Checa-Ros, Ana, et al.. (2025). SGLT2 Inhibitors: Multifaceted Therapeutic Agents in Cardiometabolic and Renal Diseases. Metabolites. 15(8). 536–536. 1 indexed citations
2.
3.
Nava, Manuel, et al.. (2024). Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?. Biomedicines. 12(2). 283–283. 1 indexed citations
4.
Checa-Ros, Ana, et al.. (2024). In silico medicine and -omics strategies in nephrology: contributions and relevance to the diagnosis and prevention of chronic kidney disease. Kidney Research and Clinical Practice. 44(1). 49–57. 3 indexed citations
5.
Calvo, Maria Clara Costa, María Sofía Martínez, Clímaco Cano, et al.. (2024). The Placental Role in Gestational Diabetes Mellitus: A Molecular Perspective. PubMed. 20(1). 10–18. 10 indexed citations
6.
Checa-Ros, Ana, et al.. (2024). Obesity and Oral Health: The Link Between Adipokines and Periodontitis. PubMed. 20(1). 25–31. 5 indexed citations
7.
8.
Checa-Ros, Ana, Antonio Muñoz‐Hoyos, Antonio Molina‐Carballo, et al.. (2023). Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial. Children. 10(7). 1121–1121. 2 indexed citations
9.
10.
Torres, Wheeler, José L. Pérez, María P. Díaz, et al.. (2023). The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis. International Journal of Molecular Sciences. 24(16). 12623–12623. 11 indexed citations
11.
Checa-Ros, Ana & Luis D’Marco. (2022). Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers. International Journal of Molecular Sciences. 23(20). 12162–12162. 15 indexed citations
12.
D’Marco, Luis, Ana Checa-Ros, Carlos Soto, et al.. (2022). Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation. Healthcare. 11(1). 72–72. 5 indexed citations
13.
Checa-Ros, Ana, Antonio Jeréz-Calero, Antonio Molina‐Carballo, Cristina Campoy, & Antonio Muñoz‐Hoyos. (2021). Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients. 13(1). 249–249. 98 indexed citations
14.
Molina‐Carballo, Antonio, et al.. (2021). Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children. Psychiatry Research. 303. 114060–114060. 12 indexed citations
15.
Checa-Ros, Ana, et al.. (2021). Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?. Epilepsy & Behavior. 124. 108332–108332. 3 indexed citations
16.
Trenité, Dorothée Kasteleijn‐Nolst, et al.. (2020). Light-emitting-diode and Grass PS 33 xenon lamp photic stimulators are equivalent in the assessment of photosensitivity: Clinical and research implications. Epilepsy Research. 165. 106377–106377. 5 indexed citations
17.
18.
19.
Checa-Ros, Ana, et al.. (2017). Clinical Considerations Derived From the Administration of Melatonin to Children With Sleep Disorders. Pediatric Neurology. 78. 61–69. 6 indexed citations
20.
Molina‐Carballo, Antonio, Ana Checa-Ros, & Antonio Muñoz‐Hoyos. (2016). Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opinion on Therapeutic Patents. 26(7). 799–814. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fude Yang Breakdown of academic impact, for papers by Sjors M. M. Lange Breakdown of academic impact, for papers by Victoria Sanborn Breakdown of academic impact, for papers by Katherine Semenkovich Breakdown of academic impact, for papers by Hohui E. Wang Breakdown of academic impact, for papers by Dariusz Juchnowicz Breakdown of academic impact, for papers by Erhan Kurt Breakdown of academic impact, for papers by Maria Chiara Santovito Breakdown of academic impact, for papers by Elżbieta Trafalska Breakdown of academic impact, for papers by Christine Girard
Rankless by CCL
2026